Pharmaceutical Regulation Expert Witnesses in California

The SEAK Expert Witness Directory contains a comprehensive list of pharmaceutical regulation expert witnesses who testify, consult and provide litigation support on pharmaceutical regulation and related issues. Pharmaceutical regulation expert witnesses and consultants on this page may form expert opinions, draft expert witness reports, and provide expert witness testimony at deposition and trial. The issues and subjects these pharmaceutical regulation expert witnesses testify regarding may include: Bio Similar Drugs, Biotech & Pharma Marketing, Cns Products, Commercially Reasonable Efforts, Cre, Dtc, Launch Delay, Medicare, Operations, Pharma Commercialization, Pharma Marketing, Pharma Sales, Pharmaceutical Contracting & Pricing, Pharmaceutical Launch, and Pharmaceuticals.

David B. Ross, MD, PhD, MBI
  • FDA Regulations & Procedures
  • Drug Safety, Clinical Trials
  • 10+ Years at FDA (CDER)
John Hosier, 30 Yrs Indust Exp
  • 50+ Products, $50M–$2B P&L
  • Adv, Promo, Mktg, Sales, CRE
  • Pharma, Biotech, Med Device
View Full Profile

John J Hosier

Pharmaceutical & Biotechnology Marketing and Sales

John Hosier Healthcare Consulting, LLC

California
Marketing, Pharmaceutical Regulation - Bio-similar drugs, Biotech & Pharma Marketing, Operations, Promotion, CNS Products, Medicare, Launch delay, Pharma Commercialization, Pharmaceutical Contracting & Pricing, Pharmaceutical Launch, Pharma Marketing, Pharma Sales, Specialty Pharma, DTC, Commercially Reasonable Efforts, CRE, Pharmaceuticals , Promotional compliance
Mr. Hosier is a strategic advisor to the life sciences industry drawing on 30 years of sales, marketing and managed markets experience in commercial healthcare organizations. He has provided insights to small molecule & biotechnology companies across multiple therapeutic areas but has maintained a heavy concentration in oncology and specialty pharmaceuticals. He has led brand launch; corporate, franchise, and strategic brand planning; commercial integration; organizational design; and operational effectiveness from multiple perspectives (as the client, as the independent consultant, and as an agency lead). Mr. Hosier’s firm has architected the launch of rare disease and oncology business units for multiple pharmaceutical clients (large and small); led development of the managed markets, trade, and distribution strategy for the launch of new chemical entities (NCEs) and 505(b)2 assets for various organizations; advised on commercially reasonable effort (CRE); and provided commerci...
You can also find Pharmaceutical Regulation Expert Witnesses in:
Connecticut, Georgia, Indiana, Maryland, Massachusetts, New Jersey, New York, Pennsylvania, Texas, and Virginia